DiscoverTransforming Biopharma‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases

‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases

Update: 2025-06-23
Share

Description

Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. 

Highlights include:

  • Why partnerships are an important part of this journey
  • How a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosis
  • Why pharma leaders should experiment with new technologies to drive real change and innovation
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases

‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases

ZS